Howard Capital Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Howard Capital Management Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.49M	Sell	28,887 -296	-1%	-$50.9K	0.34%	33
2026 Q1	$4.93M	Sell	29,183 -3,369	-10%	-$576K	0.33%	35
2025 Q4	$5.49M	Sell	32,552 -960	-3%	-$156K	0.35%	34
2025 Q3	$4.84M	Sell	33,512 -5,315	-14%	-$725K	0.31%	36
2025 Q2	$4.91M	Sell	38,827 -840	-2%	-$103K	0.34%	35
2025 Q1	$5.07M	Sell	39,667 -3,845	-9%	-$521K	0.4%	33
2024 Q4	$5.75M	Sell	43,512 -80	-0.2%	-$11.2K	0.39%	35
2024 Q3	$6.35M	Sell	43,592 -175	-0.4%	-$25.3K	0.45%	34
2024 Q2	$6.01M	Sell	43,767 -415	-0.9%	-$55.4K	0.44%	35
2024 Q1	$6.06M	Sell	44,182 -269	-0.6%	-$36.7K	0.47%	35
2023 Q4	$6.04M	Sell	44,451 -570	-1%	-$69.5K	0.52%	34
2023 Q3	$5.51M	Sell	45,021 -129	-0.3%	-$16.4K	0.53%	34
2023 Q2	$5.73M	Sell	45,150 -356	-0.8%	-$46.2K	0.53%	34
2023 Q1	$5.88M	Hold	45,506	–	–	0.62%	32
2022 Q4	$5.97M	Sell	45,506 -335	-0.7%	-$43.3K	0.72%	32
2022 Q3	$5.36M	Sell	45,841 -244	-0.5%	-$30.3K	0.68%	32
2022 Q2	$5.42M	Sell	46,085 -175	-0.4%	-$20.8K	0.64%	34
2022 Q1	$6.03M	Sell	46,260 -165	-0.4%	-$21.5K	0.55%	36
2021 Q4	$7.08M	Sell	46,425 -150	-0.3%	-$23.2K	0.58%	36
2021 Q3	$7.53M	Sell	46,575 -146	-0.3%	-$24.6K	0.7%	35
2021 Q2	$7.65M	Sell	46,721 -950	-2%	-$146K	0.72%	35
2021 Q1	$7.18M	Buy	+47,671	New	+$7.57M	0.75%	35

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Howard Capital Management Group's IBB Position: Q2 2026 in Review

Howard Capital Management Group reduced its iShares Biotechnology ETF (IBB) stake by 1% in Q2 2026, selling an estimated $50.9K and leaving 28,887 shares worth $5.49M. The position accounts for 0.34% of the portfolio, ranked #33.

Howard Capital Management Group first reported a position in IBB in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.65M in Q2 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Howard Capital Management Group held 28,887 shares of iShares Biotechnology ETF worth $5.49M as of Q2 2026.
Howard Capital Management Group sold 296 iShares Biotechnology ETF shares in Q2 2026, an estimated $50.9K.
iShares Biotechnology ETF made up 0.34% of Howard Capital Management Group's portfolio in Q2 2026, its #33 holding.
Howard Capital Management Group first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
Howard Capital Management Group's iShares Biotechnology ETF position peaked at $7.65M in Q2 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.